Skip to content
Certified ManufacturersFor manufacturers
Back to profile

Pharma Natural Inc.: due-diligence report

Public-record summary and buyer worksheet. Records can be incomplete; a listing is not product approval, an audit result or a guarantee of suitability. This report updates as source records change. Print a dated copy to retain the version you reviewed.

Share this report: https://certifiedmanufacturers.com/manufacturers/pharma-natural/due-diligence

Profile last verified: Nov 19, 2026. Report printed / reviewed on: ____________________

Certifications and licences

NSF/ANSI 455-2 GMP for Dietary Supplements

Issuer: NSF. Registry status: active. Checked: Nov 19, 2026.

Reference: Not recorded. Expiry: Not recorded.

Scope: Not recorded here; confirm with the registry and manufacturer.

Registry source: https://info.nsf.org/Certified/455GMP/Listings.asp?

Facilities

Pharma Natural Inc., 14500 NW 60 Avenue, Building 7F, Miami Lakes, FL, 33014, US — manufacturing; source: NSF/ANSI 455-2; checked Nov 19, 2026.

FDA inspection history

Dataset date: Oct 28, 2026. Facility records are matched by company and location; confirm that the site is the one in your quote. FDA inspection source.

No matched inspections in the imported dataset. This does not establish that the facility has never been inspected.

FDA recalls

Dataset date: Nov 19, 2026. Recall matches use company names and may concern a different product or facility.

Oct 4, 2023 — Class III, Terminated

Pharma-Natural Inc.: FDA sample analysis of Pharma Natural Biotin 5000 mcg Maximum Strength (30 tablets, Lot: PN10686, Exp. Date 01/24), found the biotin content was below the detection limit.

  • Pharma Natural, Biotin 5000 mcg, Maximum Strength, Dietary Supplement, 30 Tablets
FDA event 92953

Company website claims — not registry verified

Last website check: Oct 16, 2026.

“Pharma Natural manufactures a specialized offering of vitamins, minerals and herb-based nutrition products”

Last seen Oct 16, 2026. https://pharmanatural.com/natural-health-sciences/

“Our turnkey private label product manufacturing programs are designed as individual new product development projects, utilizing our qualified and approved client’s product formulation.”

Last seen Oct 16, 2026. https://pharmanatural.com/private-white-label-contract-manufacturing/

“Request More Information about our PRIVATE LABEL & WHITE LABEL CONTRACT MANUFACTURING PROGRAMS”

Last seen Oct 16, 2026. https://pharmanatural.com/private-white-label-contract-manufacturing/

“Our turnkey white label product manufacturing programs are designed as individual new product development projects, utilizing Pharma Natural proprietary product formulations from our portfolio of over 200 pre-approved nutraceutical and OTC products.”

Last seen Oct 16, 2026. https://pharmanatural.com/manufacturing/

Evidence to request from the manufacturer

Public records cannot answer these questions. Mark each item after reviewing the evidence. Blank means not assessed, not a failed audit. Notes entered here are not saved or included in a shared URL.

Request role-specific training records and the named quality contact.

21 CFR 111.12

Request a site walkthrough, sanitation controls and equipment maintenance records (also §111.25).

21 CFR 111.20

Request written identity, purity, strength, composition and contaminant specifications for your product.

21 CFR 111.70

Ask how each dietary ingredient is identified and how suppliers and certificates of analysis are qualified.

21 CFR 111.75

Request quality control procedures, release authority and handling of deviations and rejected batches.

21 CFR 111.105

Request the approved product-specific master manufacturing record and change-control process.

21 CFR 111.205

Review a completed batch record with traceability to components, processing and release.

21 CFR 111.255

Request scientifically valid test methods, sampling plans and laboratory controls for your specifications.

21 CFR 111.315

Request procedures that prevent label mix-ups and control packaging and label reconciliation.

21 CFR 111.403

Ask how storage conditions protect identity, purity, strength and composition during holding and distribution.

21 CFR 111.453

Request complaint review and investigation procedures; discuss returned-product controls under §111.503.

21 CFR 111.553

Confirm retention and access to records supporting your batches.

21 CFR 111.605